Galderma debuts global patient survey at IMCAS 2026

Written by...

The Aesthetics Journal attended IMCAS 2026 in collaboration with pharmaceutical company Galderma.

Journalists were joined by aesthetic specialists – consultant dermatologists Dr Doris Day and Dr Sabrina Fabi, and consultant plastic surgeon Mr Ash Soni – ahead of Galderma’s educational symposium, ‘Menopause in the Mirror: Challenges, Science and Aesthetic Solutions,’ on January 30.

Galderma unveiled findings from a global survey of 4,300 peri- and post-menopausal women aged 45-60 across nine countries. Results showed that over half of respondents only learnt about menopause-related skin changes through experience.

Alongside the survey, Galderma announced plans to incorporate menopausal status into all injectable aesthetic clinical trials. With around 85% of aesthetic patients being female, the company intends to leverage its dermatology expertise to advance awareness and treatment approaches for menopause-related skin changes.

Share this article: